| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.014 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |